Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs: a Cohort Prospective Study

NCT06457776 is registered in ClinicalTrials.gov with Catholic University of the Sacred Heart as lead sponsor.

NCT NCT06457776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06457776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs: a Cohort Prospective Study
Lead sponsor
Catholic University of the Sacred Heart
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2021
Completion date
January 1, 2028
Enrollment
126 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bisphosphonate-associated osteonecrosis, bisphosphonate-associated osteonecrosis of the jaw, osteonecrosis due to drug, osteonecrosis due to drugs, jaw, osteonecrosis of the jaw